Ocular Therapeutix, Inc. · NASDAQ:OCUL
Venrock Healthcare Capital Partners III, L.P.'s stake in Ocular Therapeutix, Inc. fell to 3.20% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Venrock Healthcare Capital Partners III, L.P.'s stake in Ocular Therapeutix, Inc. fell to 3.20%, 6,862,972 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 3.20%
- Shares
- 6,862,972
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 3.20% | 6,862,972 |
| VHCP Co-Investment Holdings III, LLC | 3.20% | 6,862,972 |
| Venrock Healthcare Capital Partners EG, L.P. | 3.20% | 6,862,972 |
| VHCP Management III, LLC | 3.20% | 6,862,972 |
| VHCP Management EG, LLC | 3.20% | 6,862,972 |
| Nimish Shah | 3.20% | 6,862,972 |
| Bong Y. Koh | 3.20% | 6,862,972 |
Source
Related
- Ocular Therapeutix, Inc.
- Venrock Healthcare Capital Partners III, L.P.
- Ocular Therapeutix, Inc. shareholders
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Nov 14, 2025
- Form 4 · Anderman Todd · Oct 13, 2026
- Form 4 · Heier Jeffrey S. · Oct 6, 2026
- Form 4 · Kaiser Peter · Oct 6, 2026
- Form 4 · Notman Donald · Sep 2, 2026
- Form 4 · Dugel Pravin · Aug 26, 2026